195 related articles for article (PubMed ID: 15302292)
1. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y
Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
Abramov Y; Barak V; Nisman B; Schenker JG
Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome.
Gutman G; Soussan-Gutman L; Malcov M; Lessing JB; Amit A; Azem F
Am J Reprod Immunol; 2004 May; 51(5):381-4. PubMed ID: 15212675
[TBL] [Abstract][Full Text] [Related]
4. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study.
D'Angelo A; Davies R; Salah E; Nix BA; Amso NN
Fertil Steril; 2004 Feb; 81(2):332-6. PubMed ID: 14967369
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.
Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997
[TBL] [Abstract][Full Text] [Related]
6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
Ayustawati ; Shibahara H; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
[TBL] [Abstract][Full Text] [Related]
8. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
Abramov Y; Schenker JG; Lewin A; Friedler S; Nisman B; Barak V
Hum Reprod; 1996 Jul; 11(7):1381-6. PubMed ID: 8671471
[TBL] [Abstract][Full Text] [Related]
9. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
Abramov Y; Schenker JG; Lewin A; Kafka I; Jaffe H; Barak V
Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319
[TBL] [Abstract][Full Text] [Related]
10. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
12. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
[TBL] [Abstract][Full Text] [Related]
13. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
[TBL] [Abstract][Full Text] [Related]
14. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
[TBL] [Abstract][Full Text] [Related]
16. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
Smith LP; Hacker MR; Alper MM
Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
[TBL] [Abstract][Full Text] [Related]
17. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
[TBL] [Abstract][Full Text] [Related]
18. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
19. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
Wang Q; Yang G; Yang C; Zhan B; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
[TBL] [Abstract][Full Text] [Related]
20. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
